RANKL as a prognostic marker in patients with breast cancer

Osteoprotegerin as a prognostic marker in patients with breast cancer

YKL-40 expression and its polymorphism in human breast carcinoma : A potential biomarker

Osteoprotegerin and crosslaps, new markers of bone remodeling in postmenopausal osteoporosis

Biochemical markers of bone metabolism in breast cancer patients with bone metastases

Biochemical markers of bone metabolism in breast cancer patients with bone metastases

Evaluation of Cyp17 and ER alpha genes polymorphisms in the risk of breast cancer development

Polymorphism of CYP1A1 estrogen metabolizing gene in breast cancer

Chitinase-3-like protein1 (YKL-40) as biomarker in serum of breast cancer females

Comparison between YKL 40 as anti- apoptotic protein and TRAIL as apoptotic protein in cancer patients with and without metastasis